Scholar Rock scores $300M

The latest stories trending on MedCity News.

Editor's Pick

Top Story Scholar Rock Scores $300M for Regulatory Filings & Launch Plans for Neuromuscular Disease Drug On the heels of Phase 3 data showing muscle improvement in the rare neuromuscular disease spinal muscular atrophy, Scholar Rock raised $300 million in a stock offering. U.S. and European regulatory submissions for the drug are now planned for early 2025. Sponsored Battle of the Budget: Employers vs. Rising Healthcare Costs Presented by Personify Health Join our webinar on October 24th at 1pm ET and hear from the panel as they discuss how employers are tackling the intricate challenges posed by rising healthcare costs while prioritizing employee health and well-being.

Featured News

Maven Clinic Snags $125M To Boost Fertility Program, Expand Value-Based Care Partnerships Maven Clinic's $125 million Series F funding round was led by StepStone Group and included participation from existing investors General Catalyst, Sequoia, Oak HC/FT, Icon Ventures, Dragoneer Investment Group and Lux Capital. Look Who's Talking at HLTH HLTH, scheduled for October 20-23 in Las Vegas, spotlights individuals across the healthcare ecosystem from high-powered executives such as the head of health technology at tech and social media giant Meta to Lenny Kravitz, who will talk about health equity. Here's a preview of who will be speaking at HLTH, what they'll be talking about, where and when. Video: Besides, Pharma and PBMs, Who Drives Up Drug Costs? If you thought that Big Pharma and the PBMs were the only bad guys in the saga of unreasonably high prescription drug prices in the United States, you would be wrong. Hear who else is to blame from the CEO of Blue Shield of California. MedCity FemFwd: Addressing the Maternal Health Crisis with Dr. Bayo Curry-Winchell In this episode, we're joined by Dr. Bayo Curry-Winchell, founder of Beyond Clinical Walls and medical director of urgent care clinics at Saint Mary's Regional Medical Center. She discusses the role unconscious bias plays in maternal health disparities and ways the healthcare industry can address the maternal health crisis. Why HCOs Need a Portfolio Management Approach to AI No one AI technology will address everything and solve all problems, so systems should prioritize those that promise the greatest value and ROI. What We're Still Getting Wrong in Cancer Care — Glaring Gaps in the Face of Astonishing Advancements Amidst the distress caused by a cancer diagnosis, patients are left to sort through vast amounts of information, treatment options, and concerns around efficacy and side effects, while juggling other life activities.

Resources

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Dr. Jayne Morgan, VP of Medical Affairs at Hello Heart In this month's episode, Senior Reporter Katie Adams explored some of the executive moves, exits and layoffs that recently occurred in the healthcare sector. She also interviewed Dr. Jayne Morgan, who recently became vice president of medical affairs at Hello Heart. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe